Anesthesiology, Pain Medicine · Lexington, KY
NPI
1194727701
Since 2005
Specialty
Anesthesiology, Pain Medicine
Code 207LP2900X
Group practices
8
Medicare group memberships
Hospitals
4
Hospital affiliations
120 Prosperous Pl Ste 102
Lexington, KY, 40509
Phone (859) 967-5309
Groups this clinician bills Medicare through
Medicare paid, 2024
$324K
8,701 services
Medicare patients, 2024
600
Average age 68
Drug cost, 2024
$2.8M
41,724 prescriptions
Company payments, 2025
$721
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Oliver C James II was code 99490 (chronic, principal, and transitional care management), 3,515 times for 456 patients. In total Oliver C James II billed 8,701 services in 50 codes, and Medicare paid $324K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-04-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99490 Chronic, Principal, and Transitional Care Management | Office | 3,515 | 456 | $43.69 | $154K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,947 | 118 | $0.08 | $164 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 1,680 | 382 | $33.46 | $56K |
| J7030 Infusion, normal saline solution , 1000 cc | Office | 587 | 110 | $1.98 | $1,164 |
| 62323 Nerve Block Injection - Back | Office | 101 | 77 | $161.93 | $16K |
| 99204 Office E&M - New | Office | 81 | 81 | $102.34 | $8,290 |
| 99213 Office E&M - Established | Office | 70 | 33 | $56.53 | $3,957 |
| 99454 E&M - Miscellaneous | Office | 60 | 13 | $30.05 | $1,803 |
| 99214 Office E&M - Established | Office | 50 | 39 | $78.99 | $3,950 |
| 64636 Destruction by Neurolytic Agent - Back | Office | 44 | 43 | $234.08 | $10K |
| 64635 Destruction by Neurolytic Agent - Back | Office | 44 | 43 | $436.39 | $19K |
| 64494 Nerve Block Injection - Back | Office | 42 | 38 | $93.03 | $3,907 |
| 64493 Nerve Block Injection - Back | Office | 42 | 38 | $179.00 | $7,518 |
| 20610 Joint Injection | Office | 40 | 33 | $49.72 | $1,989 |
| 77002 Imaging - Miscellaneous | Office | 34 | 28 | $75.67 | $2,573 |
By year: 2022 $264K for 5,082 services; 2023 $354K for 8,201 services; 2024 $324K for 8,701 services.
Medicare prescription drug claims, 2024
In 2024, the drug Oliver C James II prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 9,583 prescriptions and refills. In total Oliver C James II wrote 41,724 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 9,583 | 9,586 | 997 | $197K |
| Gabapentin Generic | 8,205 | 8,292 | 899 | $78K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 6,753 | 6,753 | 692 | $175K |
| Oxycodone Hcl Generic | 2,743 | 2,743 | 301 | $79K |
| Tramadol Hcl Generic | 2,542 | 2,546 | 297 | $25K |
| Pregabalin Generic | 1,602 | 1,642 | 198 | $58K |
| Morphine Sulfate Er Morphine Sulfate | 1,193 | 1,193 | 125 | $37K |
| Diclofenac Sodium Generic | 885 | 915 | 167 | $32K |
| Meloxicam Generic | 877 | 943 | 120 | $2,321 |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 831 | 831 | 67 | $65K |
| Duloxetine Hcl Generic | 659 | 690 | 80 | $6,890 |
| Xtampza Er Oxycodone Myristate | 522 | 522 | 58 | $319K |
| Methadone Hcl Generic | 452 | 452 | 47 | $11K |
| Lactulose Generic | 386 | 414 | 94 | $7,095 |
| Fentanyl Generic | 323 | 323 | 30 | $35K |
Brand drugs: - claims; generic drugs: 39,547 claims; opioid claims: 24,990.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Oliver C James II $721 ($721 in general payments such as food, travel and fees) from 7 companies. The largest payer was Globus Medical, Inc. with $488.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.